AYURVEDIC CDC MULTIMODAL PROTOCOL FOR TYPE 2 DIABETES MELLITUS AT MADHAVBAUG CLINIC: GLYCAEMIC AND CARDIOMETABOLIC OUTCOMES IN 97 DM PACKAGE PATIENTS - A RETROSPECTIVE OBSERVATIONAL STUDY

  • MD and CEO, Vaidya Sane Ayurved Laboratories Limited.
  • Chief Medical Officer, Vaidya Sane Ayurved Laboratories Limited.
  • Head Medical Operations, Vaidya Sane Ayurved Laboratories Limited.
  • Zonal Medical Head, Madhavbaug Clinics, Maharashtra, India.
  • Clinic Head, Madhavbaug Gandhinagar Pramukh Clinic, Gujarat, India.
  • Abstract
  • Keywords
  • How to Cite This Article
  • Corresponding Author

Background: Gandhinagar, Gujarat's capital city, serves a large population of government employees, administrative professionals, and their families, characterized by predominantly sedentary desk -based occupat Ions and stable incomes a demographic with high T2DM risk despite relatively controlled environmental exposures. The Gandhinagar cohort is the largest by patient number (n=97) in the Gujarat RIC DM network and the youngest (mean age 42.8 years), making it the most critical site for evaluating early intervention outcomes. Objective: To evaluate the effect of the Madhavbaug CDC Panchakarma based multimodal protocol on glycaemic, anthropometric, haemodynamic, and cardiometabolic parameters, and antidiabetic medication reduction, in 97 DM Package patients at Gandhinagar Pramukh Clinic.

Rohit Sane et, al (2026); AYURVEDIC CDC MULTIMODAL PROTOCOL FOR TYPE 2 DIABETES MELLITUS AT MADHAVBAUG CLINIC: GLYCAEMIC AND CARDIOMETABOLIC OUTCOMES IN 97 DM PACKAGE PATIENTS - A RETROSPECTIVE OBSERVATIONAL STUDY, Int. J. of Adv. Res., 14 (06), 58-63, ISSN 2320-5407. DOI URL: https://dx.doi.org/

Rohit Sane
Zonal Medical Head, Madhavbaug Clinics, Maharashtra, India.
India

Download Full Paper

Download PDF No. of Downloads: 0 | No. of Views: 0